Nurse Practitioner · Wichita, KS
NPI
1275542359
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1515 S Clifton Ave Ste 205
Wichita, KS, 67218
Phone (316) 274-8989
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
928 services
Medicare patients, 2024
454
Average age 72
Drug cost, 2024
$3.9M
8,070 prescriptions
Company payments, 2025
$38.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charla Yassine was code 99213 (office e&m - established), 508 times for 358 patients. In total Charla Yassine billed 928 services in 17 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 508 | 358 | $35.29 | $18K |
| 99214 Office E&M - Established | Facility | 307 | 190 | $55.66 | $17K |
| 36415 Venipuncture Blood Collection | Office | 17 | 13 | $8.65 | $147 |
| 99203 Office E&M - New | Facility | 17 | 17 | $40.01 | $680 |
| 77080 Standard X-ray | Office | 11 | 11 | $26.20 | $288 |
| 77091 Standard X-ray | Office | 11 | 11 | $17.98 | $198 |
By year: 2022 $119K for 8,954 services; 2023 $47K for 1,722 services; 2024 $38K for 928 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 13 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Charla Yassine prescribed most often to Medicare patients was Levothyroxine Sodium, with 693 prescriptions and refills. In total Charla Yassine wrote 8,070 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 693 | 1,656 | 161 | $6,189 |
| Tresiba Flextouch U-200 Insulin Degludec | 429 | 898 | 108 | $659K |
| Tresiba Flextouch U-100 Insulin Degludec | 415 | 900 | 115 | $268K |
| Ozempic Semaglutide | 374 | 474 | 60 | $452K |
| Jardiance Empagliflozin | 326 | 554 | 59 | $319K |
| Metformin Hcl Generic | 318 | 856 | 90 | $1,922 |
| Novolog Flexpen Insulin Aspart | 305 | 587 | 91 | $95K |
| Mounjaro Tirzepatide | 249 | 307 | 38 | $325K |
| Metformin Hcl Er Metformin Hcl | 177 | 423 | 45 | $1,756 |
| Synthroid Levothyroxine Sodium | 176 | 389 | 39 | $15K |
| Farxiga Dapagliflozin Propanediol | 174 | 245 | 31 | $136K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 165 | 257 | 52 | $53K |
| Glimepiride Generic | 160 | 437 | 47 | $1,051 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 153 | 257 | 41 | $136K |
| Humalog Kwikpen U-100 Insulin Lispro | 149 | 327 | 53 | $63K |
Brand drugs: 4,821 claims; generic drugs: 2,534 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charla Yassine $38.75 ($38.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Dexcom, Inc. with $38.75.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 1 | $38.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.